Skip to content

Age-Related Macular Degeneration (AMD) - Usability Study

Age-Related Macular Degeneration (AMD) - Usability Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00963339
Acronym
AMD
Enrollment
54
Registered
2009-08-21
Start date
2009-09-30
Completion date
2010-09-30
Last updated
2010-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Related Macular Degeneration

Keywords

AMD

Brief summary

The purpose of this study is to evaluate the usability of the Foresee Home device with intermediate AMD patients.

Detailed description

The AMD usability study is a prospective, longitudinal, multi-center, observational study of patients diagnosed with intermediate (dry) AMD who have been asked by their doctor to use the ForeseeHomeTM device to record the natural progression of their AMD, including conversion from the dry to wet stage.

Interventions

Home Monitoring

Sponsors

Notal Vision Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects diagnosed as intermediate AMD in at least one eye * Visual Acuity (VA) with habitual correction \<20/60 in the study eye * Qualified in the clinic to use the device * Ability to speak, read and understand instructions in English * Subjects with ability to comprehend and sign the informed consent/authorization

Exclusion criteria

* Evidence of macular disease other than AMD or glaucoma in the study eye * Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy * Any non-macular related ocular surgery performed within 3 months prior to study entry in the target eye

Design outcomes

Primary

MeasureTime frame
Successful self tutorial performance3 months
Ability of the subjects to operate the device as define by a successful test completion3 months
Successful unpacking and installation3 months

Secondary

MeasureTime frame
Evaluate the success rate of the interactive tutorial as defined by a reliable test result.3 month

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026